Considerations for Endpoints in Lung Transplant Clinical Trials: An ISHLT Consensus Statement.
Greenland JR, Perch M, Halloran K, Levine DJ, Morrell ED, Reed A, Shaver CM, Singer JP, Sweet SC, Vos R, Aryal S, Avdimiretz N, Burrows F, Calabrese D, Calabrese F, Campos S, Combs M, de Perrot M, Dellgren G, Diamond JM, Egan T, Ging P, Glidden DV, Goddard M, Jyothula S, Keller M, Kulkarni H, Kwakkel-van Erp JM, Lama V, Marczin N, Martinu T, Neely ML, Palmer SM, Patterson CM, Pavlisko EN, Pham C, Sanchez M, Schultz HHL, Schwerk N, Shah U, Shashaty M, Singer L, Smith P, Snyder LD, Solomon M, Verleden S, Verplancke V, Zeevi A, Todd JL.
Greenland JR, et al. Among authors: perch m.
J Heart Lung Transplant. 2025 Nov 14:S1053-2498(25)02283-1. doi: 10.1016/j.healun.2025.09.017. Online ahead of print.
J Heart Lung Transplant. 2025.
PMID: 41400593